Nuvo Research Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Joe Krupa who wrote (12953)	9/30/2003 7:26:41 PM
From: gg cox	Read Replies (1) of 14101

Page 10 of October issue of 50 Plus magazine here.. 50plus.com "Topical treatment for osteoarthritis gets the nod For Canadians suffering with osteoarthritis of the knee, a new weapon has been developed in the fight against the daily aches, pains, stiffness and sometimes debilitating effects associated with the disease. Pensaid is a topical non-steroidal anti-inflammatory drug (NSAID) recently approved by Health Canada, developed as an alternative to oral NSAIDs for treatment of osteoarthritis of the knee. Pennsaid eliminates the risk of the side effects associated with oral NSAIDs, such as gastrointestinal bleeding, and kidney and liver disease. The new topically applied treatment may be just the drug OA sufferes have been waiting for. Pennsaid works by delivering diclofenac sodium, an anti-arthritic, through the skin directly to the site of pain. Side effects of Pennsaid can include dry or irritated skin. Ask your doctor if Pennsaid is a good choice for you." Should give sales a nice boost. gg

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next